South America Glycomics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Enzymes, Instruments, Kits, and Reagents), Application (Drug Discovery and Development, Diagnostics, Immunology, Cancer, and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Contract Research Organizations)
The South America glycomics market is expected to grow from US$ 94.37 million in 2022 to US$ 194.69 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2022 to 2028.
Glycomics is a novel method for creating medicines. It draws on the knowledge that glycans serve as the primary means of altering numerous molecules in biological systems. This alteration provides those molecules with their complete, functional form. Glycans are found in most top-selling biologics and half of the therapeutic proteins (including antibodies against COVID-19). These proteins' glycans have been tailored to improve their effectiveness, lower the dosages required, and lessen negative effects. For instance, understanding the biological functions of glycans has led to their inclusion as essential ingredients in medications for the treatment of diabetes, the prevention of blood clotting, and the improvement of in vitro fertilization. Changes in the glycans on a microbe's surface are frequently connected to the microorganisms' resistance to popular medications. This property has been used in various ways, including detecting glycans in infection samples, disabling the protective biofilms formed by the infecting bacteria, and weakening the glycan-rich cell walls of microorganisms. More than 130 uncommon genetic illnesses, many of which are fatal in childhood, are brought on by errors in how human systems metabolize glycans. Understanding the glycans responsible for some of these problems has helped develop therapies. Because they can play a crucial role in how bacteria and viruses attack humans and escape our immune systems, glycans are employed in vaccinations. Additionally, more recent research on the virus that causes COVID-19 has shown infection pathways that depend on the virus's usage of human glycans. Glycans determine human blood types and reactions to organ transplants or blood transfusions. The blood or organ must match the blood group to be accepted. Researchers have modified a pig to eliminate, among other things, the principal mismatched blood group-a sugar to enable a new supply of donor organs since matched donor organs can be challenging to find quickly. A human experimental heart transplant was conducted in early 2022 through this technology. Therefore, greater adoption of glycomics in various research areas would eventually lead to a rise in the demand for these techniques, creating more research and developmental opportunities in the longer run. Such initiatives are anticipated to create new opportunities for the glycomics market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America glycomics market. The South America glycomics market is expected to grow at a good CAGR during the forecast period.
South America Glycomics Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
South America Glycomics Market Segmentation
The South America glycomics market is segmented based on product, application, end user, and country. Based on product, the South America glycomics market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment dominated the market in 2022. The enzymes segment is further segmented into glycosidases, glycosyl transferases, sialyltransferases, neuraminidases, and others. The instruments segment is also segmented into mass spectrometers, MALDI-TOF, HPLC, lectin arrays, antibody arrays, and others. Similarly, the kits segment is segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Furthermore, the reagents segment is segmented into oligosaccharides, monosaccharides, glycoproteins, and others. Based on application, the South America glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment dominated the market in 2022. Based on end user, the South America glycomics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment dominated the market in 2022. Based on country, the South America glycomics market has been categorized into Brazil, Argentina, and the Rest of South America. Brazil dominated the market in 2022.
Agilent Technologies, Inc.; Bruker Corporation; MERCK KGaA; New England Biolabs; Shimadzu Corporation; Takara Bio Inc.; Thermo Fisher Scientific Inc.; and Waters Corporation are among the leading companies in the South America glycomics market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Glycomics Market – By Product
1.3.2 SAM Glycomics Market – By Application
1.3.3 SAM Glycomics Market – By End User
1.3.4 SAM Glycomics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Glycomics Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion
5. SAM Glycomics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increased Glycomics Research and Expanding R&D Investments
5.1.2 Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals
5.3 Market Opportunities
5.3.1 Wide Applications of Glycomics
5.4 Future Trends
5.4.1 New tools in Glycomics Research
5.5 Impact Analysis
6. Glycomics Market– SAM Analysis
6.1 SAM Glycomics Market Revenue Forecast and Analysis
7. SAM Glycomics Market Analysis – By Product
7.1 Overview
7.2 SAM Glycomics Market, By Product 2022 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes Revenue and Forecast to 2028 (US$ Million)
7.3.3 Glycosidases
7.3.3.1 Overview
7.3.3.2 Glycosidases - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Glycosyltransferases
7.3.4.1 Overview
7.3.4.2 Glycosyltransferases - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Sialyltransferases
7.3.5.1 Overview
7.3.5.2 Sialyltransferases - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Neuraminidases
7.3.6.1 Overview
7.3.6.2 Neuraminidases - Revenue and Forecast to 2028 (US$ Million)
7.3.7 Others
7.3.7.1 Overview
7.3.7.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Mass Spectrometers
7.4.3.1 Overview
7.4.3.2 Mass Spectrometers- Revenue and Forecast to 2028 (US$ Million)
7.4.4 MALDI-TOF
7.4.4.1 Overview
7.4.4.2 MALDI-TOF - Revenue and Forecast to 2028 (US$ Million)
7.4.5 High-Performance Liquid Chromatography (HPLC)
7.4.5.1 Overview
7.4.5.2 High-Performance Liquid Chromatography (HPLC)- Revenue and Forecast to 2028 (US$ Million)
7.4.6 Lectin Arrays
7.4.6.1 Overview
7.4.6.2 Lectin Arrays- Revenue and Forecast to 2028 (US$ Million)
7.4.7 Antibody Arrays
7.4.7.1 Overview
7.4.7.2 Antibody Arrays - Revenue and Forecast to 2028 (US$ Million)
7.4.8 Others
7.4.8.1 Overview
7.4.8.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.5 Kits
7.5.1 Overview
7.5.2 Kits - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Glycan Release Kits
7.5.3.1 Overview
7.5.3.2 Glycan Release Kits - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Glycan Labelling Kits
7.5.4.1 Overview
7.5.4.2 Glycan Labelling Kits - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Glycan Purification Kits
7.5.5.1 Overview
7.5.5.2 Glycan Purification Kits - Revenue and Forecast to 2028 (US$ Million)
7.5.6 Others
7.5.6.1 Overview
7.5.6.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.6 Reagents
7.6.1 Overview
7.6.2 Reagents - Revenue and Forecast to 2028 (US$ Million)
7.6.3 Oligosaccharides
7.6.3.1 Overview
7.6.3.2 Oligosaccharides- Revenue and Forecast to 2028 (US$ Million)
7.6.4 Monosaccharides
7.6.4.1 Overview
7.6.4.2 Monosaccharides - Revenue and Forecast to 2028 (US$ Million)
7.6.5 Glycoproteins
7.6.5.1 Overview
7.6.5.2 Glycoproteins - Revenue and Forecast to 2028 (US$ Million)
7.6.6 Others
7.6.6.1 Overview
7.6.6.2 Others- Revenue and Forecast to 2028 (US$ Million)
8. SAM Glycomics Market Analysis – By Application
8.1 Overview
8.2 SAM Glycomics Market, By Application 2022 & 2028 (%)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 Drug Discovery and Development - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostics
8.4.1 Overview
8.4.2 Diagnostics - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunology
8.5.1 Overview
8.5.2 Immunology - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cancer
8.6.1 Overview
8.6.2 Cancer - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
9. SAM Glycomics Market Analysis – By End User
9.1 Overview
9.2 SAM Glycomics Market, By End User 2022 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)
9.4 Contract Research Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)
10. SAM Glycomics Market – Country Analysis
10.1.1 Overview
10.1.1 SAM: Glycomics Market, by country, 2022 & 2028 (%)
10.1.1.1 Brazil: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Brazil: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 Brazil: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2.1 Brazil: Glycomics Market, by Enzymes, 2019–2028 (US$ Million)
10.1.1.1.2.2 Brazil: Glycomics Market, by Instruments, 2019–2028 (US$ Million)
10.1.1.1.2.3 Brazil: Glycomics Market, by Kits, 2019–2028 (US$ Million)
10.1.1.1.2.4 Brazil: Glycomics Market, by Reagents, 2019–2028 (US$ Million)
10.1.1.1.3 Brazil: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Brazil: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Argentina: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Argentina: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 Argentina: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2.1 Argentina: Glycomics Market, by Enzymes, 2019–2028 (US$ Million)
10.1.1.2.2.2 Argentina: Glycomics Market, by Instruments, 2019–2028 (US$ Million)
10.1.1.2.2.3 Argentina: Glycomics Market, by Kits, 2019–2028 (US$ Million)
10.1.1.2.2.4 Argentina: Glycomics Market, by Reagents, 2019–2028 (US$ Million)
10.1.1.2.3 Argentina: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 Argentina: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 Rest of SAM: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Rest of SAM: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 Rest of SAM: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2.1 Rest of SAM: Glycomics Market, by Enzymes, 2019–2028 (US$ Million)
10.1.1.3.2.2 Rest of SAM: Glycomics Market, by Instruments, 2019–2028 (US$ Million)
10.1.1.3.2.3 Rest of SAM: Glycomics Market, by Kits, 2019–2028 (US$ Million)
10.1.1.3.2.4 Rest of SAM: Glycomics Market, by Reagents, 2019–2028 (US$ Million)
10.1.1.3.3 Rest of SAM: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 Rest of SAM: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Agilent Technologies, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 New England Biolabs
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Waters Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bruker Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Shimadzu Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Glycomics Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Brazil: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Glycomics Market, by Instruments – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Glycomics Market, by Kits – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Glycomics Market, by Reagents – Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina: Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Glycomics Market, by Instruments – Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: Glycomics Market, by Kits – Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina: Glycomics Market, by Reagents – Revenue and Forecast to 2028 (US$ Million)
Table 14. Argentina: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Argentina: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of SAM: Glycomics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of SAM: Glycomics Market, by Enzymes – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of SAM: Glycomics Market, by Instruments – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of SAM: Glycomics Market, by Kits – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of SAM: Glycomics Market, by Reagents – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of SAM: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of SAM: Glycomics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 23. Organic Developments in the Glycomics Market
Table 24. Inorganic Developments in the Glycomics Market
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Glycomics Market Segmentation
Figure 2. SAM Glycomics Market, By Country
Figure 3. SAM Glycomics Market Overview
Figure 4. SAM Glycomics Market, By Product
Figure 5. SAM Glycomics Market, By Country
Figure 6. SAM: PEST Analysis
Figure 7. SAM Glycomics Market Impact Analysis of Driver and Restraints
Figure 8. SAM Glycomics Market – Revenue Forecast and Analysis
Figure 9. SAM Glycomics Market, by Product 2022 & 2028 (%)
Figure 10. SAM Enzymes Revenue and Forecasts to 2028 (US$ Million)
Figure 11. SAM Glycosidases - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. SAM Glycosyltransferases - Revenue and Forecasts to 2028 (US$ Million)
Figure 13. SAM Sialyltransferases - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. SAM Neuraminidases - Revenue and Forecasts to 2028 (US$ Million)
Figure 15. SAM Others - Revenue and Forecasts to 2028 (US$ Million)
Figure 16. SAM Instruments - Revenue and Forecasts to 2028 (US$ Million)
Figure 17. SAM Mass Spectrometers - Revenue and Forecasts to 2028 (US$ Million)
Figure 18. SAM MALDI-TOF - Revenue and Forecasts to 2028 (US$ Million)
Figure 19. SAM High-Performance Liquid Chromatography (HPLC)- Revenue and Forecasts to 2028 (US$ Million)
Figure 20. SAM Lectin Arrays - Revenue and Forecasts to 2028 (US$ Million)
Figure 21. SAM Antibody Arrays - Revenue and Forecasts to 2028 (US$ Million)
Figure 22. SAM Others - Revenue and Forecasts to 2028 (US$ Million)
Figure 23. SAM Kits - Revenue and Forecasts to 2028 (US$ Million)
Figure 24. SAM Glycan Release Kits - Revenue and Forecasts to 2028 (US$ Million)
Figure 25. SAM Glycan Labelling Kits - Revenue and Forecasts to 2028 (US$ Million)
Figure 26. SAM Glycan Purification Kits - Revenue and Forecasts to 2028 (US$ Million)
Figure 27. SAM Others - Revenue and Forecasts to 2028 (US$ Million)
Figure 28. SAM Reagents - Revenue and Forecasts to 2028 (US$ Million)
Figure 29. SAM Oligosaccharides - Revenue and Forecasts to 2028 (US$ Million)
Figure 30. SAM Monosaccharides - Revenue and Forecasts to 2028 (US$ Million)
Figure 31. SAM Glycoproteins - Revenue and Forecasts to 2028 (US$ Million)
Figure 32. SAM Others - Revenue and Forecasts to 2028 (US$ Million)
Figure 33. SAM Glycomics Market, by Application 2022 & 2028 (%)
Figure 34. SAM Drug Discovery and Development - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. SAM Diagnostics - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. SAM Immunology - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. SAM Cancer - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. SAM Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. SAM Glycomics Market, by End User 2022 & 2028 (%)
Figure 40. SAM Pharmaceutical and Biotechnology Companies - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 41. SAM Contract Research Organizations - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 42. SAM Academic and Research Institutes - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 43. SAM: Glycomics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 44. SAM: Glycomics Market, by country, 2022 & 2028 (%)
Figure 45. Brazil: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Argentina: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of SAM: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
- Agilent Technologies, Inc.
- Bruker Corporation
- MERCK KGaA
- New England Biolabs
- Shimadzu Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM glycomics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM glycomics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the glycomics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution